GEAHF yields 7.00% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, GEAHF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GEAHF + JNJ for your $10,000?
Great Eagle Holdings Limited, an investment holding company, invests in, develops, and manages residential, office, retail, and hotel properties in Asia, North America, Australasia, and Europe. The company operates through Hotel Operation, Property Investment, Property Development, Other Operations, Champion REIT, Langham, and US Real Estate Fund segments. The company engages in leasing furnished apartments and properties; and flexible workspace, asset management, hotel accommodation, food and banquet, and restaurant operations. It also owns and operates three hotels under The Langham, Cordis, and Eaton brand names. In addition, the company offers property management services, including security services, staff services, maintenance and repairs, consultancy services, as well as property maintenance, leasing, and agency services. Further, it trades in building materials; invests in securities; manages real estate investment trust, computer system solutions, project advisory, treasury management, investment, and investment fund management services, as well as real estate agency services; procurement and financing, and general trading services; and issues medium term notes. The company was founded in 1963 and is headquartered in Wanchai, Hong Kong.
Full GEAHF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.